A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA

(2010) J. L. Nam et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

(2010) J.-E. Gottenberg et al.   ARTHRITIS AND RHEUMATISM

Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications

(2010) Anupa R. Menjoge et al.   DRUG DISCOVERY TODAY

Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis

(2010) Astrid Wiens et al.   PHARMACOTHERAPY

Dendritic polyglycerol sulfates as multivalent inhibitors of inflammation

(2010) J. Dernedde et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

(2010) Gert J.D. Bergman et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study

(2010) John OʼLoughlin et al.   SEXUALLY TRANSMITTED DISEASES

Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: Results from two large early arthritis cohorts

(2009) Diane van der Woude et al.   ARTHRITIS AND RHEUMATISM

Unexpected In Vivo Anti-Inflammatory Activity Observed for Simple, Surface Functionalized Poly(amidoamine) Dendrimers

(2009) Abhay S. Chauhan et al.   BIOMACROMOLECULES

Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy

(2009) Damien Portevin et al.   Journal of Translational Medicine

Rheumatoid arthritis

(2009) Lars Klareskog et al.   LANCET

Use of human tissue explants to study human infectious agents

(2009) Jean-Charles Grivel et al.   Nature Protocols

Rheumatoid arthritis market

(2009) Jeffrey G. Stoll et al.   NATURE REVIEWS DRUG DISCOVERY

Are new agents needed to treat RA?

(2009) Peter E. Lipsky   Nature Reviews Rheumatology

Dendrimers and nanomedicine: multivalency in action

(2009) Olivier Rolland et al.   NEW JOURNAL OF CHEMISTRY

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

(2008) Stanley B. Cohen et al.   ARTHRITIS AND RHEUMATISM

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

(2008) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Anti-inflammatory and immunosuppressive activation of human monocytes by a bioactive dendrimer

(2008) Séverine Fruchon et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of the cFMS Kinase Inhibitor 5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in Normal and Arthritic Rats

(2008) J. G. Conway et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Molecular mechanisms of inflammatory bone damage: emerging targets for therapy

(2008) Sonja Herman et al.   TRENDS IN MOLECULAR MEDICINE

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model

(2007) Hiroaki Ohno et al.   EUROPEAN JOURNAL OF IMMUNOLOGY